Sm Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 11 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.19 M
- Revenue Growth 21.85%
- Profit Growth 9.19%
- Ebitda -53.92%
- Net Worth 35.09%
- Total Assets 17.26%
About Sm Life Sciences
Sm Life Sciences Private Limited (SLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 26 August 2013 and has a history of 11 years and five months. Its registered office is in Rangareddy, Telangana, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹5.19 M.
Musku Reddy and Musku Rohit serve as directors at the Company.
Company Details
- Location
Rangareddy, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24100TG2013PTC089644
- Company No.
089644
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Aug 2013
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
What products or services does Sm Life Sciences Private Limited offer?
Sm Life Sciences Private Limited offers a wide range of products and services, including Pharma Ingredients & Raw Materials, API Intermediate.
Who are the key members and board of directors at Sm Life Sciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Musku Reddy  | Director | 26-Aug-2013 | Current |
| Musku Rohit | Director | 20-Jun-2014 | Current |
Financial Performance of Sm Life Sciences.
Sm Life Sciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 21.85% increase. The company also saw a slight improvement in profitability, with a 9.19% increase in profit. The company's net worth Soared by an impressive increase of 35.09%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sm Life Sciences?
In 2019, Sm Life Sciences had a promoter holding of 50.00% and a public holding of 50.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹5.19 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.40 Cr
- United Bank Of India : 0.12 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Jun 2020 | United Bank Of India | ₹0.79 M | Open |
| 14 May 2020 | United Bank Of India | ₹0.40 M | Open |
| 04 Aug 2014 | Others | ₹4.00 M | Open |
How Many Employees Work at Sm Life Sciences?
Unlock and access historical data on people associated with Sm Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sm Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sm Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
